Should tirzepatide be cycled?
Its FDA labels answer this. Tirzepatide (Mounjaro, Zepbound) is approved as a once-weekly treatment without breaks, for as long as the condition on the label is being managed. The label has no time off. The schedules passed around online that stop and restart it as a cycle are unverified. This site does not invent a schedule. Stopping is a medical decision with your prescriber, not a forum calendar. Full detail at /cycling.
Full cycling page: what was tested versus assumed
Studies in people from the compound pages this answer belongs to
- Tirzepatide
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) 2022 PMID 35658024
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2) 2021 PMID 34170647
- Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes (SURPASS-CVOT) 2025 PMID 41406444
Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.
Part of cycling and clearance. Whether peptides need a break, what a half-life actually tells you, and where a real cycling mechanism has been measured. Full detail at /cycling.